Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
clinical trials
eli lilly
fda
life sciences
national blog main
national top stories
3
×
amgen
biotech
boston blog main
boston top stories
deals
national
new york blog main
san francisco blog main
san francisco top stories
abbvie
abeona therapeutics
achaogen
affordable care act
allergan
alnylam pharmaceuticals
alzheimer's
astrazeneca
avapritinib
biohaven
biosimilar
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
brexanolone
celiac disease
cgpr
chris collins
coherus biosciences
cstone pharmaceuticals
cydan development
detroit blog main
detroit top stories
egfr
What
wins
3
×
fda
medicines
adults
allergan
alzheimer’s
approval
approved
bio
blueprint
cancer
candidate
class
congress
currently
democrats
divided
drug
elections
fallout
losses
marketing
midterm
migraine
monday
muscle
new
nod
pact
panel
pill
plenty
political
postpartum
regulatory
ret
review
roche
roundup
search
Language
unset
Current search:
wins
×
photo
×
" national top stories "
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel
